Americares honors Boehringer Ingelheim with Power of Partnership Award
Award presented at HDA Business and Leadership Conference.
Award presented at HDA Business and Leadership Conference.
National patient survey finds cost confusion, prior authorization delays can derail care, but technology can unlock price transparency, improv access.
"By forcing the closure of more than 160 PBM-affiliated retail, specialty, and mail-order pharmacies across the state, lawmakers are creating harmful new barriers for patients."
New citrus drops designed to quench your dry mouth anytime, anywhere.
Billions of small items—including select cosmetic packaging, lids, caps, coffee pods, pill bottles and more—currently slip through recycling sorting systems.
Consumers kept spending in May despite economic pressures, with beauty and lifestyle categories remaining resilient as shoppers became more selective and value-conscious.
Rooted in digestive health, the formula pairs clinically studied probiotics and botanicals to support digestive balance and promote healthier-looking skin.
The leadership changes affect key roles spanning analytics, marketing and commercial operations for the maker of brands including Aleve, Alka-Seltzer and Claritin.
Grocery chains are rethinking the role of the in-store pharmacist — and the data suggests it's their strongest play against price-driven competition.
Supporting customers on their health care journey.
NCPA is offering an early-bird registration discount of up to $100 for attendees who register for the convention or pre-convention programs by July 12.
Timed to coincide with World Refill Day, the initiative expands refill offerings across all four of L’Oréal’s business divisions and aims to make sustainable beauty choices more accessible and visible to shoppers.
OLIVE YOUNG Century City opened June 13 with grand opening celebrations and a limited-time Chamberlain Coffee collaboration.
The active ingredients work together to promote mind & body relaxation and support a better night's sleep.
The test will be whether the shifts bring savings and less complexity for patients and pharmacies.
A new Pacific Research Institute report warns that unauthorized compounded GLP-1 drugs may pose patient safety risks and hinder future pharmaceutical innovation.